Onkologie. 2011:5(6):350-354

Neuroendocrine tumors

Eva Sedláčková
Onkologická klinika VFN a 1. LF UK, Praha

Neuroendocrine tumors are a heterogeneous group of tumors with very different properties. A correct diagnosis of tumor type leads

to specific treatment. Current treatment options for these tumors include not only surgery, local therapy for hepatic metastases and,

in selected cases, chemotherapy, but significant advances have been achieved in targeted biological therapy, including the antiproliferative

effect of somatostatin analogs, TKIs and mTOR inhibitors. Major progress has also been made in therapy with unsealed sources

coupled to somatostatin analogs.

Keywords: neuroendocrine tumors, diagnosis, treatment

Published: December 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sedláčková E. Neuroendocrine tumors. Onkologie. 2011;5(6):350-354.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zamrazil V. Neuroendokrinní systém a jeho význam. Neuroendokrinní tumory. Postgraduální medicína 2010; 12: 620-626.
    2. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report. Ann Surg 1997; 225: 355-364. Go to original source... Go to PubMed...
    3. Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008; 31: 271-279. Go to original source... Go to PubMed...
    4. King J, Quinn R, Glenn DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113: 921-929. Go to original source... Go to PubMed...
    5. Modlin IM, Pavel M, Kidd M, et al. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours. Aliment Pharmacol Ther 2010; 31: 169-188.
    6. O'Toole D, Ducreux M, Bommelaer G, et al. Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 2000; 88: 770-776. Go to original source...
    7. Rinke A, Müller H, Schade-Brittinger C, et al. Placebo-controlled, double blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group. J Clin Oncol 2009; 27: 4656-4663. Go to original source... Go to PubMed...
    8. Kwekkeboom D, de Herder W, Kam B, et al. Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate: toxicity, efficacy, and survival. J Clin Oncol 2008; 26: 2124-2130. Go to original source... Go to PubMed...
    9. Bushnell DL Jr, O'Dorisio TM, O'Dorisio MS, et al. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol 2010; 28: 1652-1659. Go to original source... Go to PubMed...
    10. Oberg K. The action of interferon alpha on human carcinoid tumours. Semin Cancer Biol 1992; 3: 35-41.
    11. Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pankreas 2010; 39: 753-766. Go to original source... Go to PubMed...
    12. Kouvaraki MA, Ajani JA, Hoff P, et al. Fluorouracil, doxorubicin and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol 2004; 22: 4762-4771. Go to original source... Go to PubMed...
    13. Strosberg JR, Fine RL, Choi J, et al. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer 2010; 117: 268-275. Go to original source... Go to PubMed...
    14. Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neruoendocrine tumors. N Engl J Med 2011; 364: 514-523. Go to original source... Go to PubMed...
    15. Raymond E, Dahan L, Raoul J-L, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011; 364: 501-513. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.